FHA
TARO

Flagship Harbor Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Flagship Harbor Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-46
Closed -$3K – 2202
2020
Q2 		$3K Buy
+46
New +$3.08K ﹤0.01% 1768

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Flagship Harbor Advisors's TARO Position: Q3 2020 in Review

Flagship Harbor Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 46 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in TARO in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

  • Flagship Harbor Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 46 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2020 and held it in 1 quarter.
  • Flagship Harbor Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $3K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on Flagship Harbor Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.